全文获取类型
收费全文 | 226篇 |
免费 | 0篇 |
专业分类
儿科学 | 2篇 |
基础医学 | 95篇 |
临床医学 | 11篇 |
内科学 | 30篇 |
神经病学 | 17篇 |
特种医学 | 2篇 |
外科学 | 11篇 |
预防医学 | 17篇 |
药学 | 32篇 |
中国医学 | 3篇 |
肿瘤学 | 6篇 |
出版年
2023年 | 1篇 |
2021年 | 2篇 |
2019年 | 17篇 |
2018年 | 24篇 |
2017年 | 16篇 |
2016年 | 3篇 |
2015年 | 3篇 |
2014年 | 34篇 |
2013年 | 27篇 |
2012年 | 13篇 |
2011年 | 24篇 |
2010年 | 9篇 |
2009年 | 4篇 |
2008年 | 13篇 |
2007年 | 11篇 |
2006年 | 7篇 |
2005年 | 9篇 |
2004年 | 2篇 |
2003年 | 1篇 |
2002年 | 2篇 |
2000年 | 3篇 |
1999年 | 1篇 |
排序方式: 共有226条查询结果,搜索用时 328 毫秒
61.
Markus Wahrmann Gerald Hlavin Gottfried Fischer Lena Marinova Elisabeth Schwaiger Walter H. Hörl Gerhard J. Zlabinger Günther F. Körmöczi Franz König Georg A. Böhmig 《Human immunology》2013
Virtual crossmatching based on single-antigen bead (SAB) assays for the detection of donor-specific antibodies (DSA) has limited accuracy of predicting complement-dependent cytotoxicity crossmatch (CDCXM) results. In this study, 672 crossmatch combinations (32 allosensitized patients tested against cells from 21 high resolution-typed individuals) were analyzed to assess the potential of modified SAB tests in predicting T- or B-cell-CDCXM outcomes. Test modifications included measurement of C4d-fixation to detect complement-activating DSA ([C4d]DSA), or addition of dithiotreitol to abrogate the prozone effect ([IgG/DTT]DSA). Receiver operating characteristic (ROC) analysis revealed superior predictive accuracy of [C4d]DSA detection. Computing the mean fluorescence intensity (MFI) sum value of HLA class I [C4d]DSA in relation to T-cell-CDCXM revealed an area under the ROC curve (AUC) of 0.81. Other parameters, including DSA MFI maximum or number, were less predictive. Computing MFI sum values, AUC levels were lower for [IgG/DTT] (0.77) or [IgG]DSA detection (0.72), and did not considerably increase upon combining classifiers ([C4d] plus [IgG/DTT]: 0.82). ROC analysis revealed that [C4d]DSA detection (HLA class II) was also better at predicting B-cell-CDCXM results, even though, at very low MFI thresholds, the assay was found to provide comparably lower levels of specificity. Overall, B-cell-CDXM prediction was less precise, but could be enhanced by adjusting CDCXM thresholds to higher levels. Our data suggest particular efficiency of solid-phase complement detection as a tool for virtual crossmatching. 相似文献
62.
Marianna Resse Rossella Paolillo Amelia Casamassimi Francesco Cavalca Carmela Fiorito Ciro Maiello Claudio Napoli 《Human immunology》2013
Human leukocyte antigen (HLA) antibodies represent a significant risk factor for transplant failure. 相似文献
63.
Alexandre Bosch Santiago Llorente Jorge Eguia Anna Mrowiec Francisco Boix Ruth López-Hernández José A. Campillo Gema Salgado Maria R. Moya-Quiles Alfredo Minguela Luisa Jimeno María R. Álvarez-López Manuel Muro 《Human immunology》2014
We report an interesting case concerning an irreversible antibody-mediated rejection (AMR), associated with anti-HLA-C DSA, which occurred after a second kidney transplantation despite having determined a low number of antibodies directed against HLA-C antigens (MFI < 1000) in the previous transplantation (which was then considered to be an indicator of low risk of AMR). A 63-year-old woman was re-transplanted with pre-transplant (PrT) sensitization. On day 7 post-transplantation, oligoanuria occurred and increased MFIs for the detected PrT antibodies and other antibodies (non-detected or detected with very low PrT MFI) were observed. SAB assay also showed antibodies against the second donor HLA-C mismatches and other HLA-C antigens. Nephrologists suspected AMR and the patient was therefore treated with methylprednisolone/plasmapheresis/IVIG/anti-CD20 without improvement, which led to transplantectomy. Histologic analysis confirmed acute AMR. Interestingly, it was possible to define exactly the potential immunizing epitopes whose recognition determines the specific antibody production. So, 1st donor DSAs (detected PrT with low MFI), 2nd donor DSAs (detected PTP), and non-DSA detected PTP have several shared eplets, being the 11AVR eplet the only one present on all alleles. Thus, the recognition of 11AVR eplet in the first transplant modeled the patient’s antibody response. Therefore, we propose that donor HLA-C typing should always be performed for recipients with anti-HLA-C antibodies, and specific shared-eplets should be investigated in order to determine previous transplant mismatches. 相似文献
64.
Venkataswarup Tiriveedhi Babak Banan Saini Deepti Angaswamy Nataraju Ramsey Hachem Elbert Trulock Patterson G. Alexander Thalachallour Mohanakumar 《Human immunology》2014
Chronic rejection predominantly manifested as bronchiolitis obliterans syndrome (BOS), still remains a major problem affecting long-term outcomes in human lung transplantation (LTx). Donor specific antibodies (DSA) and infiltration of neutrophils in the graft have been associated with the development of BOS. This study determines the role of defensins, produced by neutrophils, and its interaction with α-1-antitrypsin (AAT) towards induction of airway inflammation and fibrosis which are characteristic hallmarks of BOS. Bronchoalveolar lavage (BAL) and serum from LTx recipients, BOS+ (n = 28), BOS− (n = 26) and normal healthy controls (n = 24) were analyzed. Our results show that BOS+ LTx recipients had higher α-defensins (HNP1–3) and β-defensin2 HBD2 concentration in BAL and serum compared to BOS-DSA-recipients and normal controls (p = 0.03). BOS+ patients had significantly lower serum AAT along with higher circulating concentration of HNP–AAT complexes in BAL (p = 0.05). Stimulation of primary small airway epithelial cells (SAECs) with HNPs induced expression of HBD2, adhesion molecules (ICAM and VCAM), cytokines (IL-6, IL-1β, IL-13, IL-8 and MCP-1) and growth-factor (VEGF and EGF). In contrast, anti-inflammatory cytokine, IL-10 expression decreased 2-fold (p = 0.002). HNPs mediated SAEC activation was completely abrogated by AAT. In conclusion, our results demonstrates that neutrophil secretory product, α-defensins, stimulate β-defensin production by SAECs causing upregulation of pro-inflammatory and pro-fibrotic signaling molecules. Hence, chronic stimulation of airway epithelial cells by defensins can lead to inflammation and fibrosis the central events in the development of BOS following LTx. 相似文献
65.
66.
67.
Flow cytometry is most often used in the clinical laboratory for the purpose of immunophenotyping. Here, fluorescently labeled antibodies are bound to cell surface receptors, and their presence on the cell is most often defined in bivariate terms of positive or negative, with a cutoff set relative to a nonstaining control population. It has long been recognized that the intensity of the fluorescent signal is proportional to the amount of antibody bound per cell and therefore related to the number of antigen sites expressed. This relationship makes flow cytometers, at least theoretically, capable of quantifying antigen expression in terms of molecules per cell. There were numerous obstacles to the development of such methods and clinical utilization of fluorescence intensity measures by flow cytometry has in the past been largely overlooked. The first widespread recognition of the clinical utility for fluorescence intensity measures came from laboratories where malignant phenotypes were defined by aberrant intensity of staining due to over or under expression of various cellular proteins. These semiquantitative measures were relative in nature and described staining as bright or dim compared to that normally seen in healthy individuals. Recent advances within the past decade have resulted in the development of flow cytometric methods and materials that now permit one to conduct measures of quantitative fluorescence with improved levels of control and interlaboratory precision. With these advances have come increasing interest in quantitative flow cytometry as a method to quantify the expression and activities of a variety of proteins and enzymes for diagnostic, prognostic, and therapeutic purposes. This article discusses the background and theoretical and practical considerations, as well as the current use of quantitative flow cytometry measures in the clinical laboratory. 相似文献
68.
Sandra Tafulo Jorge Malheiro Sofia Santos Leonídio Dias Manuela Almeida La Salete Martins Sofia Pedroso Cecília Mendes Luísa Lobato António Castro-Henriques 《Human immunology》2019,80(12):966-975
BackgroundHLA mismatching is a well known risk factor for worst outcomes in kidney transplantation.MethodsIn the present study, HLA antigen and eplet mismatches were determined in 151 living donor-recipient pairs transplanted between 2007 and 2014 and rejection episodes and graft survival were evaluated.ResultsWe found that high HLA-II eplet mismatch load (EpMM ≥ 13, versus low EpMM ≤ 5), was an independent predictor of AMR (adjusted HR = 14.839; P = 0.011), while HLA-II AgMM was not. We also showed that HLA-II EpMM load was a significant better predictor of AMR than AgMM (c-statistic = 0.064; P = 0.023). After discriminating HLA-II into HLA-DR and HLA-DQ loci we demonstrated that high versus low eplet mismatch load for HLA-DR (T3 ≥ 6 versus T = 0–1, p = 0.013) and HLA-DQ (T3 ≥ 7 versus T = 0–1, p = 0.009) are independent predictors for AMR.HLA-II EpMM increased discrimination performance of the classical HLA-II AgMM risk model (IDI, 0.061, 95%CI: 0.005–0.195) for AMR. Compared with AgMM, HLA-II eplet model adequately reclassified 13 of 17 patients (76.5%) with AMR and 92 of 134 patients (68.7%) without AMR (cfNRI, 0.785, 95%CI: 0.300–1.426).ConclusionsOur study evidences that eplet-based matching is a refinement of the classical HLA antigen mismatch analysis in LDKT and is a potential biomarker for personalized assessment of alloimmune risk. 相似文献
69.
Schumacher A 《Journal of immunological methods》2007,323(1):24-30
P-selectin glycoprotein ligand-1 (PSGL-1) is expressed on leukocytes and its expression is elevated in asthma and chronic obstructive pulmonary disease. This study assessed whether the cell stabilisation solution Cyto-Chex is able to preserve such quantitative differences for delayed testing. Peripheral blood was mixed with Cyto-Chex and stored refrigerated or at ambient temperature. Aliquots were tested by flow cytometry 2 to 168 h after collection for PSGL-1, CD3, CD4, CD8, and CD16 expression and marker-positive cell counts. Compared with controls a marked reduction of staining intensities is seen at all time points for all markers, irrespective of the storage temperature. This loss of bright staining did not or only moderately decrease marker-positive cell counts except for PSGL-1+ lymphocytes which declined in parallel with staining intensity. These findings indicate that Cyto-Chex is not able to preserve the expression or affinity to antibodies of surface markers to allow delayed determination of quantitative differences or detection of weakly staining cells. Immunophenotyping is mostly possible for 7 days after collection, however, this has to be tested for each marker and cell type of interest. 相似文献
70.
Robert S. Liwski Anna L. Greenshields David M. Conrad Cathi Murphey Robert A. Bray Jorge Neumann Howard M. Gebel 《Human immunology》2018,79(1):28-38
The flow cytometric crossmatch (FCXM) assay, which detects the presence of donor specific HLA antibodies in patient sera, is a cornerstone of HLA compatibility testing. Since relatively long FCXM assay turnaround times may contribute to transplant delays and increased graft ischemia time, we developed and validated two modified crossmatch procedures, namely the Halifax and Halifaster FCXM protocols. These protocols reduce FCXM assay time?>60% and simplify their set-up without compromising quality or sensitivity. Optimization of the FCXM (the Halifax protocol) includes a 96-well tray platform, reduced wash times, increased serum to cell suspension volume ratio, shortened incubations and higher incubation temperature. The Halifaster protocol is a further modification, employing methods that improve lymphocyte purity compared to density gradient centrifugation (96?±?2.63% vs 69?±?19.06%), reduce cell isolation time (by?~40%) and conserve FCXM assay reagents. Importantly, linear regression analysis of the median channel fluorescence shift (MCFS) values revealed excellent concordance (R2 of 0.98–0.99) among all three FCXM protocols (standard vs Halifax vs Halifaster). Finally, a retrospective review of 2013 crossmatches performed using the Halifax protocol demonstrated excellent correlation with the virtual crossmatch (95.7% and 96.8% specificity and sensitivity, respectively) regarding the identification of donor specific antibodies (HLA-A/B/DR) assigned based on the single antigen bead (SAB) assay testing with a 2000 mean fluorescence intensity (MFI) cutoff. Implementation of the Halifax or Halifaster protocols will expedite pre-transplantation work-up and improve patient care. 相似文献